Benzinga

AUGUST 22, 2024

Cyclo Therapeutics' TransportNPC™ Phase 3 clinical trial for Trappsol ® Cyclo™ for the treatment of Niemann-Pick Disease Type C1, a rare and fatal genetic disease, is fully enrolled and results from the 48-week interim analysis are expected in the middle of 2025 NEWARK, N.J. and GAINESVILLE, Fla.,

Debt Financing 45

Debt Financing Finance Marketability 45

Benzinga

OCTOBER 21, 2024

The transaction is expected to close in early 2025, subject to customary closing conditions. and UBS Investment Bank are acting as financial advisors and providing debt financing for the transaction. Secureworks shareholders, including Dell Technologies (NYSE: DELL ), will receive $8.50 per share in cash.

Technology 40

Technology Debt Financing Marketability Banking 40

Benzinga

JUNE 23, 2022

Debt financing for this transaction will be provided by OrbiMed Advisors, LLC. sales and Japan royalties or supply payments based on supply of TYMLOS for sale in Japan) during any consecutive 12-month period prior to December 31, 2025. per share in cash plus a CVR of $1.00 per share in cash plus a CVR of $1.00

Debt Financing 40

Debt Financing Finance 40

Reynolds Holding

JUNE 13, 2024

Thank you for inviting me to testify today on the Securities and Exchange Commission’s Fiscal Year (FY) 2025 budget request. debt capital markets facilitate 75 percent of debt financing of non-financial corporations. Furthermore, the SEC announced it will close our Salt Lake City office early in FY 2025.

Technology 45

Technology Marketability Banking Start-ups 45

Benzinga

AUGUST 1, 2024

Transaction Details: Total estimated consideration for the Teads acquisition is approximately $1 billion, on a cash free, debt free basis, including an upfront payment of $725 million, subject to standard adjustments, and a deferred cash payment of $25 million. subject to customary funding conditions.

Debt Financing 40

Debt Financing EBITDA Finance Banking 40

Scott Mashuda

MARCH 31, 2025

With continued interest rate cuts and significant private equity capital seeking deals in 2025, current market dynamics present compelling sell-side opportunities for well-prepared sellers to achieve premium valuations. I Know How To Run My Company, I Can Sell It Myself.

Banking 52

Banking Capital Structure Private Equity Firm Debt Financing 52

Reynolds Holding

NOVEMBER 13, 2024

The regulations’ prohibitions and reporting requirements go into effect on January 2, 2025. Beginning on January 2, 2025, some “covered transactions” will be prohibited outright, while others will require post-transaction notification to the newly created Office of Global Transactions within the U.S. investment fund (31 C.F.R.

Treasury 45

Treasury Equity Debt Financing Technology 45

Cooley M&A

FEBRUARY 14, 2025

Download the report Whats covered inside: Key PE moves witnessed in 2024 and where deals got done The new administration and what to expect from potential policy changes Where regulatory watchdogs sharpened their focus Ways PE is deploying artificial intelligence technology How market conditions shaped debt financing Uptiering as a liability management (..)

Equity 59

Equity Debt Financing Finance Technology 59

Global Finance

APRIL 5, 2025

Market participants entered the year hoping for a robust revival in M&A, IPO, and debt financing activities. Despite indicators that 2025 could bring a sharper rebound in M&A activity, many of the headwinds that curtailed growth in recent years arent abating. That should change in 2025, Van Oostende says.

Banking 52

Banking Private Equity Firm Finance Debt Financing 52

Benzinga

APRIL 9, 2025

million cash each within nine months and 18 months from the closing.

Debt Financing 40

Debt Financing Finance 40

Benzinga

MAY 21, 2025

BOSTON, May 21, 2025 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc., Optinose shareholders approved the merger proposal at Optinose's special meeting of shareholders held on May 16, 2025, and following completion of the merger Optinose's common stock will be delisted from the Nasdaq Global Select Market.

Debt Financing 40

Debt Financing Finance Marketability 40

Benzinga

MAY 27, 2025

Strive CEO Matt Cole to discuss the company's proposed alpha-generating Bitcoin strategies during his 11:54 AM PT keynote on May 27, 2025 at the Bitcoin for Corporations Symposium in Las Vegas, Nevada. The PIPE was priced at $1.35 The exercise price for warrants in this PIPE transaction is $1.35

Alpha 40

Alpha Treasury Beta Finance 40

Benzinga

MARCH 4, 2025

March 04, 2025 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. This transaction, which closed on March 3, 2025, marks a significant milestone in Star's growth strategy. Transaction Highlights Transaction values ADT at a cash-free, debt-free enterprise value of $12.65 OLD GREENWICH, Conn., million, funded in part by $2.5

Equity 40

Equity Debt Financing Enterprise Value EBITDA 40

Benzinga

MARCH 19, 2025

March 19, 2025 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals and Optinose, Inc. The upfront consideration of $9 per share represents a 50% premium to Optinose's closing trading price on March 19, 2025. The Boards of both Paratek and Optinose have unanimously approved the transaction.

Debt Financing 40

Debt Financing Finance Marketability 40

Benzinga

MAY 20, 2025

. - Transaction has received irrevocable support from over 35% of Renergen shareholders and is expected to close during the third quarter of 2025 ahead of the planned QLE spin out. - The Company has entered into a term sheet with institutional debt investors for a potential debt financing of $30 million aggregate principal amount.

EBITDA 40

EBITDA Finance Debt Financing Marketability 40

Benzinga

FEBRUARY 3, 2025

03, 2025 (GLOBE NEWSWIRE) -- Outbrain Inc. million shares of common stock of Outbrain (valued at approximately $263 million based on the closing price of Outbrain's common stock as of January 31, 2025, of $6.01). The replay will be available until February 17, 2025. NEW YORK, Feb. subject to customary funding conditions.

EBITDA 40

EBITDA Debt Financing Marketability Technology 40

Reynolds Holding

DECEMBER 5, 2024

The Outbound Rules will take effect on January 2, 2025, and will add a new layer of diligence to most U.S. making a loan or providing other debt financing that is either convertible or affords the right to be involved in the target’s management in certain capacities; 3. investment. See our prior mailers here and here.

Treasury 59

Treasury Technology Equity Start-ups 59

Cooley M&A

FEBRUARY 3, 2025

That said, Q4 was the strongest quarter for M&A involving VC-backed startups since early 2023 and we see signs of strong momentum heading into 2025. Lets take a closer look at key developments in tech M&A during 2024 and what we could see in 2025. 7] The OISP took effect on January 2, 2025.

Equity 59

Equity Technology Marketability Start-ups 59